Tevogen Bio Holdings (TVGN) said late Friday that it broadened its relationship with Microsoft (MSFT) to expand its artificial intelligence-focused collaboration while building a technology designed to help with predictive precision T-cell targeting.
Shares of Tevogen advanced 30% as intraday trading volume soared to more than 48.5 million from a daily average of about 2.9 million.
Aurora Mobile (JG) said Monday that its business-oriented AI agent platform GPTBots.ai integrated the DeepSeek R1 large language model.
Shares skyrocketed 166% as intraday trading volume surged to over 28.5 million from a daily average of about 15,000.
Akero Therapeutics (AKRO) said Monday a phase 2b study of its lead product candidate, efruxifermin, showed a "statistically significant" reversal of compensated cirrhosis caused by metabolic dysfunction-associated steatohepatitis, or MASH.
Shares surged more than 91% as intraday trading volume catapulted to over 11.7 million from a daily average of about 723,000.
Price: 1.75, Change: +0.40, Percent Change: +29.70
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。